A study explains how age reshapes the blood system. In both humans and mice, a few stem cells out-compete their neighbors and gradually take over blood production. The loss of diversity results in a ...

Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

A new study in the journal Nature explains how age reshapes the blood system. In both humans and mice, a few stem cells, or "clones", outcompete their ...

In today's interview, we speak to Aadel Chaudhuri (Vice Chair for Translational Research, Mayo Clinic) about the promise of liquid biopsy in cancer and beyond.

Plus: UK halts Israel trade talks over Gaza offensive, sanctions settlers; Musk to cut political donations, stay Tesla CEO ...

Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...

The reconstructed Pony Coupe Concept is kickstarting serious discussions about building a production version of the N Vision 74 and three gorgeous Genesis EVs.

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past ...

Americans' fixation on protein is reaching a fever pitch with new high-protein products constantly hitting the shelves. But ...